Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids

Endocrinology

Volumn 141, Issue 11, 2000, Pages 4262-4269

  Muller, M B ^a   Landgraf, R ^a   Preil, J ^a   Sillaber, I ^a   Kresse, A E ^a   Keck, M E ^a   Zimmermann, S ^a   Holsboer, F ^a   Wurst, W ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GLUCOCORTICOID; OXYTOCIN; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; GENOTYPE; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE DETERMINATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDIAN EMINENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; STRESS; THALAMUS MIDLINE NUCLEUS;

EID: 0033695490     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.11.7767     Document Type: Article

References (47)

1. Physiology and pharmacology of corticotropin releasing factor
2. Corticotropin-releasing factor receptors physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
3. The rationale for the corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
4. Corticotropin-releasing factor receptors from molecular biology to drug design
5. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat
6. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats
7. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related bahavior in socially defeated rats
8. Differential behavioral effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain
9. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
10. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
11. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
12. Vasopressinergic control of pituitary-adrenocorticotropin secretion comes of age
13. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
14. CRF type 1 receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation
15. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells
16. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system
17. Chronic psychological stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: Relationship to subordinate status
18. Corticotropin-releasing factor immunore-active neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy
19. Interaction of corticotropin-releasing factor and arginine-vasopressin in adrenocorticotropin secretion in vivo
20. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholammes and vasopressin
21. Disruption of feeding behavior in CRH receptor 1 deficient mice is dependent on glucocorticoids
22. Intruder-evoked aggression in isolated and non-isolated mice effects of psychomotor stimulants and L-DOPA
23. Novel ligand specificity of pituitary vasopressin receptors in the rat
24. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat
25. Release of vasopressin and oxytocin within the brain and into blood: Microdialysis and antisense targeting
26. Structure and comparison of the oxytocin and vasopressin genes from rat
27. Nitric oxide synthase increases in hypothalamic magnocellular neurons after salt loading in the rat. An immunohistochemical and in situ hybridization study
28. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain
29. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin
30. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
31. Combined adminstration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects
32. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons
33. The paraventricular nucleus of the hypothalamus cytoarchitectonic subdivisions and the organization of projections to the pituitary, dorsal vagal complex and spinal cord as demonstrated by retrograde fluorescence double labeling methods
34. The hypothalamopituitary-adrenal axis in rodents corticotropin releasing hormone/vasopressin co-existence and cytokine effects
35. The neurophysin-containing innervation of the forebrain of the mouse
36. Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function
37. Turnover of corticotropin releasing factor and vasopressin in the median eminence and control of pituitary-adrenal activity
38. Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: A novel mechanism of regulating adrenocorticotropic hormone secretion?
39. Suppressive vasopressin response to emotional stress
40. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat
41. Immunocytochemical distribution of corticotropin-releasing hormone type-1 (CRF1)-like immunoreactivity in the mouse brain: Light microscopy analysis using an antibody directed against the C-terminus
42. Social stress in rats and mice
43. Incidence of arrhythmias and heart rate variability in wild-type rats exposed to social stress
44. Immunohistochemical evidence that most rat corticotrophs contain β-adrenergic receptors
45. Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat
46. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion
47. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated